EJ

Errol James Desouza

Active Director Director DIN 00053201
DIN 00053201 First appointment Dec 1997 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 10 active board seats
Past companies 3 historical roles
Total affiliations 13 Since Dec 1997
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 29 Dec 1997
Active appointments 13
Total timeline records 13

Errol James Desouza (DIN 00053201) has 13 recorded board appointments in Indian companies, the first from December 1997, of which 13 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1997
Wardex Pharmaceuticals Private Limited Director · 2025 – present
Current
Franco Indian Therapeutics Pvt. Ltd Director · 2025 – present
Current
Franco Indian Research Private Limited Director · 2025 – present
Current
Princeps Pharmaceuticals Private Limited Director · 2025 – present
Current
Laboratoires Griffon Private Limited Director · 2025 – present
Current
Franco Indian Medicare Pvt Ltd Director · 2025 – present
Current
Franco-Indian Remedies Private Limited Director · 2025 – present
Current
Franco-Indian Holdings Private Limited Director · 2024 – present
Current
Current
Curatas Pharmaceuticals Llp Partner · 2016 – present
Current
Pharmabest Investments Private Limited Director · 2009 – present
Current
Curabest Investments Private Limited Director · 2004 – present
Current
Medibest Investments Private Limited Director · 1997 – present
Current

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available